{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T05:41:18Z","timestamp":1771047678173,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Henan Provincial Medical Science and Technology Research Plan Joint Construction Project","award":["LHGJ20200313"],"award-info":[{"award-number":["LHGJ20200313"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671491"],"award-info":[{"award-number":["81671491"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-024-12758-w","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T13:03:53Z","timestamp":1723122233000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hypermethylated RASAL1\u2019s promotive role in chemoresistance and tumorigenesis of choriocarcinoma was regulated by TET2 but not DNMTs"],"prefix":"10.1186","volume":"24","author":[{"given":"Xianling","family":"Zeng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruifang","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruixia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,8]]},"reference":[{"key":"12758_CR1","doi-asserted-by":"crossref","unstructured":"Kaur B. Pathology of gestational trophoblastic disease (GTD). Best practice & research Clinical obstetrics & gynaecology 2021, 74:3\u201328.","DOI":"10.1016\/j.bpobgyn.2021.02.005"},{"issue":"4","key":"12758_CR2","doi-asserted-by":"publisher","first-page":"430","DOI":"10.2478\/raon-2022-0038","volume":"56","author":"N Lukinovic","year":"2022","unstructured":"Lukinovic N, Malovrh EP, Takac I, Sobocan M, Knez J. Advances in diagnostics and management of gestational trophoblastic disease. Radiol Oncol. 2022;56(4):430\u20139.","journal-title":"Radiol Oncol"},{"issue":"11","key":"12758_CR3","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.6004\/jnccn.2019.0053","volume":"17","author":"NR Abu-Rustum","year":"2019","unstructured":"Abu-Rustum NR, Yashar CM, Bean S, Bradley K, Campos SM, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, et al. Gestational trophoblastic neoplasia, Version 2.2019, NCCN Clinical Practice guidelines in Oncology. J Natl Compr Cancer Network: JNCCN. 2019;17(11):1374\u201391.","journal-title":"J Natl Compr Cancer Network: JNCCN"},{"issue":"Suppl 1","key":"12758_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/ijgo.13877","volume":"155","author":"HYS Ngan","year":"2021","unstructured":"Ngan HYS, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, Lurain JR, Massuger L. Diagnosis and management of gestational trophoblastic disease: 2021 update. Int J Gynaecol Obstet. 2021;155(Suppl 1):86\u201393.","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"12758_CR5","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.ygyno.2008.09.005","volume":"112","author":"RS Berkowitz","year":"2009","unstructured":"Berkowitz RS, Goldstein DP. Current management of gestational trophoblastic diseases. Gynecol Oncol. 2009;112(3):654\u201362.","journal-title":"Gynecol Oncol"},{"key":"12758_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.bpobgyn.2021.01.006","volume":"74","author":"MC Winter","year":"2021","unstructured":"Winter MC. Treatment of low-risk gestational trophoblastic neoplasia. Best Pract Res Clin Obstet Gynecol. 2021;74:67\u201380.","journal-title":"Best Pract Res Clin Obstet Gynecol"},{"issue":"1","key":"12758_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ajog.2010.06.072","volume":"204","author":"JR Lurain","year":"2011","unstructured":"Lurain JR. Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia. Am J Obstet Gynecol. 2011;204(1):11\u20138.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"12758_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/GCO.0000000000000674","volume":"33","author":"JJ Clark","year":"2021","unstructured":"Clark JJ, Slater S, Seckl MJ. Treatment of gestational trophoblastic disease in the 2020s. Curr Opin Obstet Gynecol. 2021;33(1):7\u201312.","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"10110","key":"12758_CR9","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1016\/S0140-6736(17)32894-5","volume":"390","author":"E Ghorani","year":"2017","unstructured":"Ghorani E, Kaur B, Fisher RA, Short D, Joneborg U, Carlson JW, Akarca A, Marafioti T, Quezada SA, Sarwar N, et al. Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia. Lancet. 2017;390(10110):2343\u20135.","journal-title":"Lancet"},{"issue":"4","key":"12758_CR10","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1007\/s11033-020-05341-6","volume":"47","author":"HO Caglar","year":"2020","unstructured":"Caglar HO, Biray Avci C. Alterations of cell cycle genes in cancer: unmasking the role of cancer stem cells. Mol Biol Rep. 2020;47(4):3065\u201376.","journal-title":"Mol Biol Rep"},{"issue":"16","key":"12758_CR11","doi-asserted-by":"publisher","first-page":"7053","DOI":"10.7150\/thno.41388","volume":"10","author":"H Li","year":"2020","unstructured":"Li H, Feng Z, He ML. Lipid metabolism alteration contributes to and maintains the properties of cancer stem cells. Theranostics. 2020;10(16):7053\u201369.","journal-title":"Theranostics"},{"key":"12758_CR12","doi-asserted-by":"crossref","unstructured":"Barbato L, Bocchetti M, Di Biase A, Regad T. Cancer Stem cells and targeting strategies. Cells 2019, 8(8).","DOI":"10.3390\/cells8080926"},{"key":"12758_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3389\/fmolb.2020.00079","volume":"7","author":"AP Thankamony","year":"2020","unstructured":"Thankamony AP, Saxena K, Murali R, Jolly MK, Nair R. Cancer Stem Cell plasticity - A Deadly Deal. Front Mol Biosci. 2020;7:79.","journal-title":"Front Mol Biosci"},{"issue":"10","key":"12758_CR14","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1038\/s41388-019-1128-4","volume":"39","author":"AT Vessoni","year":"2020","unstructured":"Vessoni AT, Filippi-Chiela EC, Lenz G, Batista LFZ. Tumor propagating cells: drivers of tumor plasticity, heterogeneity, and recurrence. Oncogene. 2020;39(10):2055\u201368.","journal-title":"Oncogene"},{"issue":"24","key":"12758_CR15","doi-asserted-by":"publisher","first-page":"15279","DOI":"10.1021\/acs.jmedchem.0c01336","volume":"63","author":"PS Kharkar","year":"2020","unstructured":"Kharkar PS. Cancer Stem Cell (CSC) inhibitors in Oncology-A Promise for a better therapeutic outcome: state of the art and future perspectives. J Med Chem. 2020;63(24):15279\u2013307.","journal-title":"J Med Chem"},{"issue":"5","key":"12758_CR16","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/nrg.2016.13","volume":"17","author":"AP Feinberg","year":"2016","unstructured":"Feinberg AP, Koldobskiy MA, G\u00f6nd\u00f6r A. Epigenetic modulators, modifiers and mediators in cancer aetiology and progression. Nat Rev Genet. 2016;17(5):284\u201399.","journal-title":"Nat Rev Genet"},{"key":"12758_CR17","doi-asserted-by":"crossref","unstructured":"Ponomarev A, Gilazieva Z, Solovyeva V, Allegrucci C, Rizvanov A. Intrinsic and extrinsic factors impacting Cancer Stemness and Tumor Progression. Cancers (Basel) 2022, 14(4).","DOI":"10.3390\/cancers14040970"},{"issue":"2","key":"12758_CR18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2019;20(2):69\u201384.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"12758_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto MA, Huang RY, Jackson RA, Thiery JP. EMT: 2016. Cell. 2016;166(1):21\u201345.","journal-title":"Cell"},{"issue":"3","key":"12758_CR20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.devcel.2019.04.010","volume":"49","author":"W Lu","year":"2019","unstructured":"Lu W, Kang Y. Epithelial-mesenchymal plasticity in Cancer Progression and Metastasis. Dev Cell. 2019;49(3):361\u201374.","journal-title":"Dev Cell"},{"issue":"1","key":"12758_CR21","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s13287-022-02904-1","volume":"13","author":"F Ju","year":"2022","unstructured":"Ju F, Atyah MM, Horstmann N, Gul S, Vago R, Bruns CJ, Zhao Y, Dong QZ, Ren N. Characteristics of the cancer stem cell niche and therapeutic strategies. Stem Cell Res Ther. 2022;13(1):233.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"12758_CR22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.jhep.2010.06.036","volume":"54","author":"DF Calvisi","year":"2011","unstructured":"Calvisi DF, Ladu S, Conner EA, Seo D, Hsieh JT, Factor VM, Thorgeirsson SS. Inactivation of ras GTPase-activating proteins promotes unrestrained activity of wild-type Ras in human liver cancer. J Hepatol. 2011;54(2):311\u20139.","journal-title":"J Hepatol"},{"issue":"4","key":"12758_CR23","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3892\/or.2012.1920","volume":"28","author":"F Qiao","year":"2012","unstructured":"Qiao F, Su X, Qiu X, Qian D, Peng X, Chen H, Zhao Z, Fan H. Enforced expression of RASAL1 suppresses cell proliferation and the transformation ability of gastric cancer cells. Oncol Rep. 2012;28(4):1475\u201381.","journal-title":"Oncol Rep"},{"issue":"1","key":"12758_CR24","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1053\/j.gastro.2008.09.063","volume":"136","author":"M Ohta","year":"2009","unstructured":"Ohta M, Seto M, Ijichi H, Miyabayashi K, Kudo Y, Mohri D, Asaoka Y, Tada M, Tanaka Y, Ikenoue T, et al. Decreased expression of the RAS-GTPase activating protein RASAL1 is associated with colorectal tumor progression. Gastroenterology. 2009;136(1):206\u201316.","journal-title":"Gastroenterology"},{"issue":"11","key":"12758_CR25","doi-asserted-by":"publisher","first-page":"8325","DOI":"10.1007\/s13277-015-3523-y","volume":"36","author":"H Liu","year":"2015","unstructured":"Liu H, Li Z, Li L, Peng H, Zhang Z. EBP1 suppresses growth, migration, and invasion of thyroid cancer cells through upregulating RASAL expression. Tumour Biology: J Int Soc Oncodevelopmental Biology Med. 2015;36(11):8325\u201331.","journal-title":"Tumour Biology: J Int Soc Oncodevelopmental Biology Med"},{"issue":"3","key":"12758_CR26","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1136\/jclinpath-2016-204132","volume":"70","author":"J Knief","year":"2017","unstructured":"Knief J, Reddemann K, Lazar-Karsten P, Herhahn T, Petrova E, Wellner U, Thorns C. Prognostic implications of RASAL1 expression in oesophagogastric adenocarcinoma. J Clin Pathol. 2017;70(3):274\u20136.","journal-title":"J Clin Pathol"},{"issue":"7579","key":"12758_CR27","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nature15748","volume":"527","author":"KR Fischer","year":"2015","unstructured":"Fischer KR, Durrans A, Lee S, Sheng J, Li F, Wong ST, Choi H, El Rayes T, Ryu S, Troeger J, et al. Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature. 2015;527(7579):472\u20136.","journal-title":"Nature"},{"issue":"7579","key":"12758_CR28","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nature16064","volume":"527","author":"X Zheng","year":"2015","unstructured":"Zheng X, Carstens JL, Kim J, Scheible M, Kaye J, Sugimoto H, Wu CC, LeBleu VS, Kalluri R. Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature. 2015;527(7579):525\u201330.","journal-title":"Nature"},{"issue":"9742","key":"12758_CR29","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(10)60280-2","volume":"376","author":"MJ Seckl","year":"2010","unstructured":"Seckl MJ, Sebire NJ, Berkowitz RS. Gestational trophoblastic disease. Lancet. 2010;376(9742):717\u201329.","journal-title":"Lancet"},{"key":"12758_CR30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.bpobgyn.2020.12.001","volume":"74","author":"C Lok","year":"2021","unstructured":"Lok C, Frijstein M, van Trommel N. Clinical presentation and diagnosis of gestational trophoblastic disease. Best Pract Res Clin Obstet Gynecol. 2021;74:42\u201352.","journal-title":"Best Pract Res Clin Obstet Gynecol"},{"issue":"34","key":"12758_CR31","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1038\/onc.2010.215","volume":"29","author":"A Singh","year":"2010","unstructured":"Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene. 2010;29(34):4741\u201351.","journal-title":"Oncogene"},{"issue":"10","key":"12758_CR32","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","volume":"14","author":"T Shibue","year":"2017","unstructured":"Shibue T, Weinberg RA. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat Reviews Clin Oncol. 2017;14(10):611\u201329.","journal-title":"Nat Reviews Clin Oncol"},{"issue":"5","key":"12758_CR33","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.cell.2012.02.008","volume":"148","author":"W Guo","year":"2012","unstructured":"Guo W, Keckesova Z, Donaher JL, Shibue T, Tischler V, Reinhardt F, Itzkovitz S, Noske A, Z\u00fcrrer-H\u00e4rdi U, Bell G, et al. Slug and Sox9 cooperatively determine the mammary stem cell state. Cell. 2012;148(5):1015\u201328.","journal-title":"Cell"},{"issue":"8","key":"12758_CR34","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1002\/emmm.201302827","volume":"5","author":"FA Siebzehnrubl","year":"2013","unstructured":"Siebzehnrubl FA, Silver DJ, Tugertimur B, Deleyrolle LP, Siebzehnrubl D, Sarkisian MR, Devers KG, Yachnis AT, Kupper MD, Neal D, et al. The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance. EMBO Mol Med. 2013;5(8):1196\u2013212.","journal-title":"EMBO Mol Med"},{"issue":"4","key":"12758_CR35","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133(4):704\u201315.","journal-title":"Cell"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12758-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12758-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12758-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T13:04:24Z","timestamp":1723122264000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12758-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,8]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12758"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12758-w","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,8]]},"assertion":[{"value":"15 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal studies were approved by the Animal Use and Care Committee of Xi\u2019an Jiaotong University. The authors confirmed that all animal experiments were performed in accordance with ARRIVE guidelines (). Also, the experiments with human tissues was also approved by the Ethics Committee of the First Affiliated Hospital of Xi\u2019an Jiaotong University. All the methods\/study was in accordance with the declaration of Helsinki, and all methods were conducted in accordance with relevant guidelines and regulations. The human tissues from all subjects were obtained with informed consents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"977"}}